natgillin/translations-raw huggingface dataset:
Administer Bravecto chewable tablets at or around the time of feeding. 
Bravecto tableto dajte ob času hranjenja ali približno takrat.
For optimal control of tick infestation, the timing of retreatment depends on the tick species. 
Za optimalni nadzor infestacije s klopi je čas ponovnega zdravljenja odvisen od vrste klopov.
Hypersensitivity reactions in humans have been reported. 
Pri ljudeh so poročali o preobčutljivostnih reakcijah.
Bodyweight of dog (kg) 
Telesna teža psa (kg)
The product should not be used by persons with a hypersensitivity to the active substance or to any of the excipients (see contraindications, section 4.3). 
Zdravila ne smejo uporabljati osebe s preobčutljivostjo za učinkovino ali katerokoli pomožno snov (glejte Kontraindikacije, poglavje 4.3).
1 chewable tablet 2 chewable tablets 4 chewable tablets 
VELIKOST PAKIRANJA 1 žvečljiva tableta 2 žvečljivi tableti 4 žvečljive tablete
Strength and number of tablets to be administered 
Jakost in število tablet, ki jih je treba dati
Step 1: Immediately before use, open the sachet and remove the pipette. 
Prvi korak: Neposredno pred uporabo odprite vrečko in izvlecite merilno kapalko.
Incubation of fluralaner in the presence of carprofen or warfarin in dog plasma at maximum expected plasma concentrations did not reduce the protein binding of fluralaner, carprofen or warfarin. 
Inkubacija fluralanerja v prisotnosti karprofena ali varfarina v plazmi psa pri največjih pričakovanih plazemskih koncentracijah ni zmanjšala vezave fluralanerja, karprofena ali varfarina na beljakovine.
Avoid the application of more than 1 ml of solution at any one spot as it could cause some of the solution to run or drip off the dog. 
Ne nanašajte več kot 1 ml raztopine na posamezno mesto, ker bi je lahko nekaj steklo ali odkapljalo s psa.
PARTICULARS TO APPEAR ON THE OUTER PACKAGE Carton Box 
PODATKI NA ZUNANJI OVOJNINI KARTONSKA ŠKATLA
Fluralaner is a potent inhibitor of parts of the arthropod nervous system by acting antagonistically on ligand-gated chloride channels (GABA-receptor and glutamate-receptor). 
Fluralener je močan inhibitor delov živčnega sistema artropodov s svojim antagonističnim delovanjem na ligand odvisne kloridne kanal (GABA receptor in receptor glutamata).
Cardboard box with 1 aluminium foil blister sealed with PET aluminium foil lid stock containing 1, 2 or 4 chewable tablets. 
Kartonska škatla z 1 aluminijastim pretisnim omotom, zavarjenim s prevleko PET aluminijasta folija, ki vsebuje 1, 2 ali 4 žvečljive tablete.
Keep the pipette in the sachet until use. 
Merilno kapalko hranite v vrečki do uporabe.
The following other signs shortly after administration were uncommonly observed: apathy/tremors/anorexia (0.9% of treated cats) or vomiting/hypersalivation (0.4% of treated cats). 
Drugi znaki, ki so bili občasno opaženi kratek čas po dajanju zdravila, so: apatija/tresenje/neješčnost (0,9% zdravljenih mačk) ali bruhanje/povečano slinjenje (0,4 % zdravljenih mačk).
Marketing authorisation holder: Intervet International B. V. 
Imetnik dovoljenja za promet z zdravilom: Intervet International B. V.
Treatment schedule: 
Shema zdravljenja
Newly emerged fleas on a dog are killed before viable eggs are produced. 
Bolhe, ki se na novo pojavijo na psih, so ubite, preden proizvedejo za življenje sposobna jajčeca.
Pharmacotherapeutic group: Ectoparasiticides for systemic use ATCvet code: QP53B E02 
Farmakoterapevtska skupina: Učinkovine proti ektoparazitom za sistemsko zdravljenje Oznaka ATC vet: QP53B E02
Unchanged fluralaner is excreted in feces and to a very low extent in urine. 
Nespremenjen fluralaner se izloči z fecesom in v zelo majhnem delu z urinom.
Oral uptake of the product at the maximum recommended dose of 93 mg fluralaner/kg body weight was well tolerated in cats, apart from some self-limiting salivation and coughing or vomiting immediately after administration. 
Peroralni vnos največjega priporočenega odmerka (93 mg fluralanerja/kg telesne teže) so mačke dobro prenašale, z izjemo nekaj samoomejevanega slinjenja in kašljanja ali bruhanja neposredno po dajanju.
Each carton box contains 1 or 2 pipettes. 
V vsaki kartonski škatli sta 1 ali 2 merlni kapalki.
In the absence of available data, this veterinary medicinal product should not be used on kitten less than 11 weeks old and /or cats weighing less than 1.2 kg. 
Ker ni ustreznih podatkov, se to zdravilo za uporabo v veterinarski medicini ne sme uporabljati za mladiče mlajše od 11 tednov starosti in/ali za mačke, ki tehtajo manj kot 1,2 kg.
Oral uptake of the product at the maximum recommended dose was well tolerated in cats, apart from some self-limiting salivation and coughing or vomiting immediately after administration. 
Peroralni vnos največjega priporočenega odmerka so mačke dobro prenašale, z izjemo samo omejevanega slinjenja in kašljanja ali bruhanja neposredno po dajanju.
Fluralaner is readily absorbed from the topical administration site into the hair, skin and subjacent tissues, from where it is slowly absorbed into the vascular system. 
Po tlokalnem dajanju se fluralaner zlahka absorbira iz mesta nanosa v dlako, kožo in pod njo ležeča tkiva, od koder se počasi absorbira v krvni obtok.
Unit dose pipette made of laminated aluminium/polypropylene foil closed with an HDPE cap and packed in a laminated aluminium foil sachet. 
Kapalka z enoto odmerka je narejena iz laminirane aluminijasto/polipropilenske folije, zaprta s HDPE zaporko in pakirana v vrečko iz laminirane aluminijaste folije.
Each ml contains 280 mg fluralaner. 
1 ml vsebuje fluralaner 280 mg.
Wash hands thoroughly with soap and water immediately after use of the product. 
Takoj po uporabi zdravila si roke dobro umijte z milom in vodo.
The product should not be administered at intervals shorter than 8 weeks as the safety for shorter intervals has not been tested. 
Zdravilo se ne sme dajati v razmikih, krajših od 8 tednov, ker varnost za krajše razmike ni bila testirana.
and fleas (Ctenocephalides spp.) 
(Ctenocephalides spp.)
Place the pipette tip on the base of the skull of the cat. 
Nastavite vrh merilne kapalke na kožo na spodnji del lobanje mačke.
CLINICAL PARTICULARS 4.1 Target species 
KLINIČNI PODATKI 4.1 Ciljne živalske vrste Psi.
Lot: {number} 
Lot{številka}
Some marbling, speckles or both may be visible. 
Včasih je marmorina ali ima majhne lise ali oboje.
The product should not be used by persons with a hypersensitivity to the active substance or to any of the excipients (see section Contraindications). 
Zdravila ne smejo uporabljati osebe s preobčutljivostjo za učinkovino ali katerokoli pomožno snov (glejte poglavje Kontraindikacije).
Safety was demonstrated in breeding, pregnant and lactating animals treated with overdoses of up to 3 times the maximum recommended dose. 
Varnost je bila dokazana pri živalih za vzrejo in pri živalih v času brejosti in laktacije, ki so jim dajali odmerke, ki so bili do 3krat večji od največjega priporočenega odmerka.
Fluralaner is highly bound to plasma proteins and might compete with other highly bound active substances such as non-steroidal anti-inflammatory drugs (NSAIDs) and the coumarin derivative warfarin. 
Fluralaner se močno veže na plazemske beljakovine in lahko tekmuje z drugimi močno vezanimi učinkovinami, kot so nesteroidna protivnetna zdravila (NSAID), in kumarinski derivat varfarin.
The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports) 
Pogostost neželenih učinkov je določena po naslednjem dogovoru: - zelo pogosti (neželeni učinki se pokažejo pri več kot 1 od 10 zdravljenih živali) - pogosti (pri več kot 1, toda manj kot 10 živali od 100 zdravljenih živali) - občasni (pri več kot 1, toda manj kot 10 živali od 1.000 zdravljenih živali) - redki (pri več kot 1, toda manj kot 10 živali od 10.000 zdravljenih živali) - zelo redki (pri manj kot 1 živali od 10.000 zdravljenih živali, vključno s posameznimi primeri.
Maize starch 
Koruzni škrob
for small cats 1.2 - 2.8 kg for medium-sized cats >2.8 - 6.25 kg for large cats >6.25 - 12.5 kg 
za majhne mačke 1,2 - 2,8 kg za srednje velike mačke >2,8 - 6,25 kg za velike mačke >6,25 - 12,5 kg
Care should be taken to avoid contact with the eyes of the animal. 
Paziti je treba, da zdravilo za uporabo v veterinarski medicini ne pride v oči živali.
Fluralaner is readily systemically absorbed from the topical administration site, reaching maximum concentrations in plasma between 3 and 21 days after administration. 
Po tlokalnem dajanju se fluralaner zlahka absorbira iz mesta nanosa in doseže maksimalno koncentracijo v krvni plazmi med 3. in 21. dnevom po dajanju.
Cap does not come off. 
Zaporka se ne da odstraniti.
Mild and transient gastrointestinal effects such as diarrhoea, vomiting, inappetence, and drooling were commonly observed in clinical trials (1.6% of treated dogs). 
Blagi in prehodni gastrointestinalni učinki, kot na primer diareja, bruhanje, pomanjkanje teka in slinjenje so bili pogosto opaženi med kliničnimi testiranji ( 1,6 % zdravljenih psov).
The prolonged persistence and slow elimination from plasma (t1/2 = 21 days) and the lack of extensive metabolism provide effective concentrations of fluralaner for the duration of the inter-dosing interval. 
Podaljšano zadrževanje in počasno izločanje iz plazme (t1/2 = 21 dni) in pomanjkanje ekstenzivnega metabolizma zagotavljajo učinkovite koncentracije fluralanerja v času med dvema odmerkoma.
In order to avoid contact, disposable protective gloves obtained with this product at the point of sale must be worn when handling and administering the product. 
Da bi se izognili stiku, je pri rokovanju in dajanju zdravila treba nositi zaščitne rokavice za enkratno uporabo, ki so priložene izdelku ob nakupu.
The pipettes should be kept in the outer packaging to prevent solvent loss or moisture uptake. 
Merilne kapalke hranite v zunanji ovojnini, da se ne izgublja vehikel in da se ne navzamejo vlage.
The prolonged persistence and slow elimination from plasma (t1/2 = 12 days) and the lack of extensive metabolism provide effective concentrations of fluralaner for the duration of the inter-dosing interval. 
Podaljšano zadrževanje in počasno izločanje iz plazme (t1/2 = 12 dni) in pomanjkanje metabolizmazagotavljajo učinkovite koncentracije fluralanerja v času med dvema odmerkoma.
In the absence of available data, this veterinary medicinal product should not be used on puppies less than 8 weeks old and /or dogs weighing less than 2 kg. 
Ker ni ustreznih podatkov, se to zdravilo za uporabo v veterinarski medicini ne sme uporabljati za mladiče do 8 tednov starosti oziroma za pse, ki tehtajo manj kot 2 kg.
Special precautions to be taken by the person administering the veterinary medicinal product to animals 
Posebni previdnostni ukrepi, ki jih mora izvajati oseba, ki živalim daje zdravilo za uporabo v veterinarski medicini
Skin rashes tingling or numbness have been reported in a small number of individuals after skin contact. 
Po stiku s kožo so pri manjšem številu posameznikov poročali o izpuščajih, mravljinčenju ali otrplosti kože.
For optimal control of flea infestation, the veterinary medicinal product should be administered at intervals of 12 weeks. 
Za optimalni nadzor infestacije z bolhami je treba zdravilo za uporabo v veterinarski medicini dajati v 12-tedenskih razmikih.
In case of contact with the eyes, immediately rinse thoroughly with water. 
Zdravilo lahko povzroči draženje oči.V kolikor pride zdravilo v stik z očmi, ga takoj temeljito sperite z vodo
0.4 ml 0.89 ml 1.79 ml 3.57 ml 5.0 ml 
0,4 ml 0,89 ml 1,79 ml 3,57 ml
Strength and number of pipettes to be administered 
Jakost in število kapalk, ki jih je treba dati
The safety of the veterinary medicinal product in breeding, pregnant and lactating dogs has been demonstrated. 
Varnost zdravila za uporabo v veterinarski medicini pri psih za vzrejo, v obdobju brejosti in laktacije je bila dokazana.
Step 2: The cat should be standing or lying with its back horizontal for easy application. 
Drugi korak: Mačka naj med nanašanjem stoji ali leži, hrbet pa naj bo vodoraven za lažji nanos.
The pipette should be held by the base or by the upper rigid portion below the cap in an upright position (tip up) for opening it. 
Kapalko je treba držati za njeno bazo ali za trdi del pod zaporko v pokončnem položaju.
The onset of efficacy is within 12 hours for fleas (C. felis) and within 48 hours for ticks (I. ricinus). 
Učinkovanje se začne v 12 urah na bolhe (C. felis) in v 48 urah na klope (I. ricinus).
The safety of the veterinary medicinal product has not been established during pregnancy and lactation. 
Varnost zdravila za uporabo v veterinarski medicini v obdobju brejosti in laktacije ni bila dokazana.
Diethyltoluamide (DEET) Acetone 
Seznam pomožnih snovi dimetilacetamid glikofurol dietiltoluamid (DEET) aceton
Bravecto 112.5 mg (2-4.5 kg) Bravecto 250 mg (>4.5 -10 kg) Bravecto 500 mg (>10 -20 kg) Bravecto 1,000 mg (>20 -40 kg) Bravecto 1,400 mg (>40 -56 kg) fluralaner 
Bravecto 112,5 mg (2-4,5 kg) Bravecto 250 mg (>4.5-10 kg) Bravecto 500 mg (>10-20 kg) Bravecto 1000 mg (>20-40 kg) Bravecto 1400 mg (>40-56 kg)
For cats above 12.5 kg body weight, use a combination of two pipettes that most closely matches the body weight. 
Za mačke s telesno težo nad 12,5 kg uporabite kombinacijo dveh kapalk, ki najbolj ustreza telesni teži.
Place the pipette tip vertically against the skin between the shoulder blades of the dog. 
Konico merilne kapalke postavite navpično na kožo med lopaticama.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION 
Datum zadnjega podaljšanja dovoljenja za promet:
Fluralaner was well tolerated in Collies with a deficient multidrug-resistance-protein 1 (MDR1 -/-) following single oral administration at 3 times the maximum recommended dose (168 mg/kg bodyweight). 
Fluralaner so dobro prenašali koliji z nezadostnim MDR 1 -/- po enkratnem peroralnem dajanju 3krat večjega odmerka od priporočenega (168 mg/kg telesne teže).
Step 2: The dog should be standing or lying with its back horizontal during application. 
Drugi korak: Pes naj med dajanjem stoji ali leži, hrbet pa naj bo vodoraven.
Intervet International B. V. Wim de Körverstraat 35 5831 AN Boxmeer The NETHERLANDS 
Intervet International B. V. Wim de Körverstraat 35 5831 AN Boxmeer NIZOZEMSKA
For dogs above 56 kg bodyweight, use a combination of two tablets that most closely matches the bodyweight. 
Za pse s telesno težo nad 56 kg uporabite kombinacijo dveh tablet, ki se najbolj približa telesni teži.
For dogs above 56 kg body weight, use a combination of two pipettes that most closely matches the body weight. 
Za pse s telesno težo nad 56 kg uporabite kombinacijo dveh kapalk, ki najbolj ustreza telesni teži.
The veterinary medicinal product was well tolerated in Collies with a deficient multidrug-resistanceprotein 1 (MDR1 -/-) following single oral administration at 3 times the recommended dose (168 mg/kg bodyweight). 
Zdravilo za uporabo v veterinarski medicini so dobro prenašali koliji z nezadostnim MDR 1 -/- po enkratnem peroralnem dajanju 3krat večjega odmerka od priporočenega (168 mg/ kg telesne teže).
The veterinary medicinal product was well tolerated in collies with a deficient multidrug-resistanceprotein 1 (MDR1 -/-) following single oral administration at 3 times the recommended dose. 
Zdravilo za uporabo v veterinarski medicini so dobro prenašali koliji z nezadostnim MDR 1 -/- po enkratnem oralnem dajanju 3krat večjega odmerka od priporočenega.
on the dog. 
na psih.
EU/2/13/158/018-019 112.5 mg EU/2/13/158/022-023 250 mg EU/2/13/158/026-027 500 mg 
EU/2/13/158/022-023 250 mg EU/2/13/158/026-027 500 mg
Intervet International B. V. Wim de Körverstraat 35 5831 AN Boxmeer 
Intervet International B. V. Wim de Körverstraat 35 5831 AN Boxmeer Niozozemska
For the treatment of tick and flea infestations on dogs. 
Za zdravljenje infestacije z bolhami in klopi pri psih.
The product should be applied on cats up to 6.25 kg body weight in one spot at the base of the skull and in two spots on cats greater than 6.25 kg bodyweight. 
Zdravilo dajte mačkam, ki tehtajo do 6,25 kg,na eno mesto oz. na dve mesti mačkam, ki tehtajo več kot 6,25 kg na spodnji del lobanje.
Safety was demonstrated in puppies aged 8-9 weeks and weighing 2.0-3.6 kg treated with overdoses of up to 5 times the maximum recommended dose on three occasions at shorter intervals than recommended (8-week intervals). 
Varnost je bila dokazana pri psičkih, starih 8-9 tednov in težkih 2,0-3,6 kg, ki so jim dajali odmerke, ki so bili do 5krat večji od priporočenega odmerka, trikrat v krajših razmikih, kot je priporočeno (8tedenski razmiki).
Safety was demonstrated in kitten aged 11-13 weeks and weighing 1.2-1.5 kg treated with overdoses of up to 5 times the maximum recommended dose on three occasions at shorter intervals than recommended (8-week intervals). 
Varnost pri mačkah, starih 11-13 tednov in težkih 1,2-1,5 kg, zdravljenih z do 5krat večjimi odmerki od največjega priporočenega trikrat v krajših razmikih, kot je priporočeno (8-tedenski razmiki), je bila dokazana.
Do not use this veterinary medicinal product after the expiry date which is stated on the blister after EXP. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, navedenega na ovojnini za EXP. Rok uporabnosti zdravila se nanaša na zadnji dan v navedenem mesecu.
For spot-on use 
Za peroralno uporabo
Bravecto should be administered in accordance with the following table (corresponding to a dose of 40 - 94 mg fluralaner/kg body weight): 
Bravecto je treba dajati v skladu z naslednjo preglednico (en odmerek 40-94 mg fluralanerja/kg telesne teže ):
No adverse reactions were observed following topical administration to kitten aged 11-13 weeks and weighing 1.2-1.5 kg treated with overdoses of up to 5 times the maximum recommended dose (93 mg, 279 mg and 465 mg fluralaner/kg body weight) on three occasions at shorter intervals than recommended (8-week intervals). 
Ko so mačkam, starim 11-13 tednov in težkim 1,2-1,5 kg, dajali lokalno do 5krat večje odmerke od največjega priporočenega (93 mg, 279 mg in 465 mg fluralanerja/kg telesne teže) trikrat v krajših razmikih, kot je priporočeno (8-tedenski razmiki), niso opazili nobenih neželenih učinkov.
During clinical field testing, no interactions between Bravecto chewable tablets for dogs and routinely used veterinary medicinal products were observed. 
Med kliničnimi testiranji niso opazili medsebojnih delovanj med Bravecto žvečljivimi tabletami za pse in drugimi zdravili za uporabo v veterinarski medicini, ki se uporabljajo rutinsko.
The onset of effect is within 8 hours of attachment for fleas (C. felis) and 12 hours of attachment for ticks (I. ricinus). 
Učinkovanje se začne v 8 urah po pritrditvi za bolhe (C. felis) in v 12 urah po pritrditvi za klope (I. ricinus).
Bravecto chewable tablets 
Bravecto žvečljive tablete
For optimal control of tick and flea infestation, the product should be administered at intervals of 12 weeks. 
Za optimalni nadzor infestacije s klopi in bolhami je treba zdravilo za uporabo v veterinarski medicini dajati v 12-tedenskih razmikih.
112.5 mg fluralaner 250 mg fluralaner 500 mg fluralaner 
112,5 mg fluralaner
For the treatment of tick and flea infestations in cats. 
INDIKACIJA(E) Za zdravljenje infestacije z bolhami in klopi pri mačkah.
EU/2/13/158/016 (112.5 mg, 1 pipette) EU/2/13/158/017 (112.5 mg, 2 pipettes) EU/2/13/158/020 (250 mg, 1 pipette) EU/2/13/158/021 (250 mg, 2 pipettes) EU/2/13/158/024 (500 mg, 1 pipette) EU/2/13/158/025 (500 mg, 2 pipettes) EU/2/13/158/028 (1,000 mg, 1 pipette) EU/2/13/158/029 (1,000 mg, 2 pipettes) EU/2/13/158/030 (1,400 mg, 1 pipette) EU/2/13/158/031 (1,400 mg, 2 pipettes) 
EU/2/13/158/016 (112,5 mg, 1merilna kapalka) EU/2/13/158/017 (112.5 mg, 2 merilni kapalki) EU/2/13/158/020 (250 mg, 1 merilna kapalka) EU/2/13/158/021 (250 mg, 2 merilni kapalki) EU/2/13/158/024 (500 mg, 1 merilna kapalka) EU/2/13/158/025 (500 mg, 2 merilni kapalki) EU/2/13/158/028 (1000 mg, 1 merilna kapalka) EU/2/13/158/029 (1000 mg, 2 merilni kapalki) EU/2/13/158/030 (1400 mg, 1 merilna kapalka) EU/2/13/158/031 (1400 mg, 2 merilni kapalki)
This veterinary medicinal product is a systemic insecticide and acaricide that provides immediate and persistent flea (Ctenocephalides felis) and tick (Ixodes ricinus) killing activity for 12 weeks. 
To zdravilo za uporabo v veterinarski medicini je sistemski insekticid in akaricid, ki zagotavlja takojšnje in trajno ubijanje bolh (Ctenocephalides felis) in klopov (Ixodes ricinus) skozi 12 tednov.
Each chewable tablet of Bravecto contains: 
NAVEDBA UČINKOVIN(E) IN DRUG(E)IH SESTAVIN Vsaka žvečljiva tableta Bravecto vsebuje:
This veterinary medicinal product is a systemic insecticide and acaricide that provides: - immediate and persistent flea (Ctenocephalides felis and Ctenocephalides canis) killing activity for 12 weeks, and - immediate and persistent tick (Ixodes ricinus, Rhipicephalus sanguineus and Dermacentor reticulatus) killing activity for 12 weeks. 
To zdravilo za uporabo v veterinarski medicini je sistemski insekticid in akaricid, ki zagotavlja - takojšnje in trajno ubijanje bolh (Ctenocephalides felis in Ctenocephalides canis) skozi 12 Tednov in - takojšnje in trajno ubijanje klopov skozi 12 tednov (Ixodes ricinus, Rhipicephalus sanguineus in Dermacentor reticulatus).
The cap should be rotated clockwise or counter clockwise one full turn. 
Zaporko zavrtite v smeri urnega kazalca ali v nasprotni smeri urnega kazalca za en cel obrat.
EU/2/13/158/018 (112.5 mg, 1 pipette) EU/2/13/158/019 (112.5 mg, 2 pipettes) EU/2/13/158/022 (250 mg, 1 pipette) EU/2/13/158/023 (250 mg, 2 pipettes) EU/2/13/158/026 (500 mg, 1 pipette) EU/2/13/158/027 (500 mg, 2 pipettes) 
EU/2/13/158/018 (112,5 mg, 1merilna kapalka) EU/2/13/158/019 (112.5 mg, 2 merilni kapalki) EU/2/13/158/022 (250 mg, 1 merilna kapalka) EU/2/13/158/023 (250 mg, 2 merlni kapalki) EU/2/13/158/026 (500 mg, 1 merilna kapalka) EU/2/13/158/027 (500 mg, 2 merilni kapalki)
Intervet International B.V. 
IME IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM Intervet International B.V.
Pork liver flavour Sucrose 
Aroma svinjskih jeter Saharoza
Do not use in case of hypersensitivity to the active substance or to any of the excipients. 
KONTRAINDIKACIJE Ne uporabljajte v primeru preobčutljivosti na zdravilno učinkovino ali na katero od pomožnih snovi.
The onset of efficacy is within 8 hours for fleas (C. felis) and 12 hours for ticks (I. ricinus). 
Učinkovanje se zaćne v 8 urah na muhe (C. felis) in v 12 urah na klope (L. ricinus).
for very small dogs (2-4.5 kg) for small dogs (>4.5-10 kg) for medium-sized dogs (>10-20 kg) for large dogs (>20-40 kg) for very large dogs (>40-56 kg) 
za zelo majhne pse (2-4,5 kg) za majhne pse (>4.5-10 kg) za srednje velike pse (>10-20 kg) za velike pse (>20-40 kg) za zelo velike pse (>40-56 kg)
This veterinary medicinal product is a systemic insecticide and acaricide that provides: - immediate and persistent flea (Ctenocephalides felis and C. canis) killing activity for 12 weeks, - immediate and persistent tick (Ixodes ricinus, Rhipicephalus sanguineus and Dermacentor reticulatus) killing activity for 12 weeks. 
To zdravilo za uporabo v veterinarski medicini je sistemski insekticid in akaricid, ki zagotavlja - takojšnje in trajno ubijanje bolh (Ctenocephalides felis in C. cnmis ) skozi 12 tednov, - takojšnje in trajno ubijanje klopov (Ixodes ricinus in Dermacentor reticulatus skozi 12 tednov.
QUANTITY OF THE ACTIVE SUBSTANCE 
KOLIČINA UČINKOVINE fluralaner
Can be used in breeding, pregnant and lactating dogs. 
Zdravilo se lahko uporablja pri psih za vzrejo, v dobi brejosti in laktacije.
for very small dogs 2 - 4.5 kg for small dogs >4.5 - 10 kg for medium-sized dogs >10 - 20 kg for large dogs >20 - 40 kg for very large dogs >40 - 56 kg 
za zelo majne pse 2-4,5 kg za majhne pse >4.5-10 kg za srednje velike pse >10-20 kg za velike pse >20-40 kg za zelo velike pse >40-56 kg